Hajime Senjo

674 citations
31 papers · 222 indexed · h-index 9
Topics
Hematopoietic Stem Cell Transplantation (9 papers)Immune Cell Function and Interaction (7 papers)Acute Myeloid Leukemia Research (6 papers)
Partner nations
JapanUnited States

In The Last Decade

Hajime Senjo

24 papers receiving 217 citations

Peers

Hajime Senjo
Comparison fields: 5 of 54
  • Hematology 79
  • Oncology 54
  • Pathology and Forensic Medicine 49
  • Molecular Biology 45
  • Immunology 36
Replace Sung-Nam Lim with:
Sung-Nam Lim South Korea
Noriyuki Yamakawa Japan
Juan José Rodríguez‐Sevilla Spain
Po‐Shen Ko Taiwan
Robert M. Fox United States
Shiyuan Zhou China
Bérengère Gruson France
Fatma Visal Okur Türkiye
George Mo United States
Noa G. Holtzman United States
Hajime Senjo relative to Sung-Nam Lim South Korea Sung-Nam Lim's profile →
Citations per field
00.5×2.9×
Sung-Nam Lim · 1×
Citations per year

Countries citing papers authored by Hajime Senjo

Since Specialization
Citations

This map shows the geographic impact of Hajime Senjo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hajime Senjo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hajime Senjo more than expected).

Fields of papers citing papers by Hajime Senjo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hajime Senjo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hajime Senjo. The network helps show where Hajime Senjo may publish in the future.

Co-authorship network of co-authors of Hajime Senjo

This figure shows the co-authorship network connecting the top 25 collaborators of Hajime Senjo. A scholar is included among the top collaborators of Hajime Senjo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hajime Senjo. Hajime Senjo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 0
3 27
4 0
5 2
6 16
7 2
8 12
9 3
10 20
11 0
12 7
13 10
14 0
15 2
16 37
17 8
18 10
19 0
20 0

About Hajime Senjo

Hajime Senjo is a scholar working on Hematology, Immunology and Genetics, having authored 31 papers that have together received 222 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (9 papers), Immune Cell Function and Interaction (7 papers) and Acute Myeloid Leukemia Research (6 papers). The work is most often cited by research in Hematology (79 citations), Genetics (30 citations) and Pathology and Forensic Medicine (49 citations). Hajime Senjo has collaborated with scholars based in Japan and United States. Frequent co-authors include Takakazu Higuchi, Sadamu Okada, Osamu Takahashi, Daigo Hashimoto, Takanori Teshima, Shuichi Ota, Akio Mori, Kenji Hirata, Koh Izumiyama and Ryo Kikuchi. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026